BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10982548)

  • 1. Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointimal formation after vascular injury in rat model: potential application of ribozyme strategy to treat cardiovascular disease.
    Yamamoto K; Morishita R; Tomita N; Shimozato T; Nakagami H; Kikuchi A; Aoki M; Higaki J; Kaneda Y; Ogihara T
    Circulation; 2000 Sep; 102(11):1308-14. PubMed ID: 10982548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta 1 mRNA inhibits neointima formation in rat carotid artery after balloon injury.
    Ando H; Fukuda N; Kotani M; Yokoyama Si; Kunimoto S; Matsumoto K; Saito S; Kanmatsuse K; Mugishima H
    Eur J Pharmacol; 2004 Jan; 483(2-3):207-14. PubMed ID: 14729108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapeutic strategy for atherosclerosis: ribozyme oligonucleotides against apolipoprotein(a) selectively inhibit apolipoprotein(a) but not plasminogen gene expression.
    Morishita R; Yamada S; Yamamoto K; Tomita N; Kida I; Sakurabayashi I; Kikuchi A; Kaneda Y; Lawn R; Higaki J; Ogihara T
    Circulation; 1998 Nov; 98(18):1898-904. PubMed ID: 9799211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric DNA-RNA hammerhead ribozyme targeting PDGF A-chain mRNA specifically inhibits neointima formation in rat carotid artery after balloon injury.
    Kotani M; Fukuda N; Ando H; Hu WY; Kunimoto S; Saito S; Kanmatsuse K
    Cardiovasc Res; 2003 Jan; 57(1):265-76. PubMed ID: 12504837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-RNA chimeric hammerhead ribozyme to transforming growth factor-beta(1) mRNA inhibits the exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats.
    Teng J; Fukuda N; Hu WY; Nakayama M; Kishioka H; Kanmatsuse K
    Cardiovasc Res; 2000 Oct; 48(1):138-47. PubMed ID: 11033116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribozyme to human TGF-beta1 mRNA inhibits the proliferation of human vascular smooth muscle cells.
    Su JZ; Fukuda N; Hu WY; Kanmatsuse K
    Biochem Biophys Res Commun; 2000 Nov; 278(2):401-7. PubMed ID: 11097849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-encoded hammerhead ribozyme to PDGF A-chain mRNA inhibits neointima formation after arterial injury.
    Lin ZH; Fukuda N; Suzuki R; Takagi H; Ikeda Y; Saito S; Matsumoto K; Kanmatsuse K; Mugishima H
    J Vasc Res; 2004; 41(4):305-13. PubMed ID: 15192266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribozyme-mediated inhibition of rat leukocyte-type 12-lipoxygenase prevents intimal hyperplasia in balloon-injured rat carotid arteries.
    Gu JL; Pei H; Thomas L; Nadler JL; Rossi JJ; Lanting L; Natarajan R
    Circulation; 2001 Mar; 103(10):1446-52. PubMed ID: 11245651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of growth of human gingival fibroblasts by chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta 1.
    Yusa J; Fukuda N; Sato S; Matsmoto K; Mugishima H; Kamoi K
    J Periodontol; 2005 Aug; 76(8):1265-74. PubMed ID: 16101357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels: potential role of HGF in cardiovascular disease.
    Nakano N; Morishita R; Moriguchi A; Nakamura Y; Hayashi SI; Aoki M; Kida I; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Hypertension; 1998 Sep; 32(3):444-51. PubMed ID: 9740609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of TGF-beta(1) antisense S-oligonucleotide on synthesis and accumulation of matrix proteoglycans in balloon catheter-injured neointima of rabbit carotid arteries.
    Merrilees M; Beaumont B; Scott L; Hermanutz V; Fennessy P
    J Vasc Res; 2000; 37(1):50-60. PubMed ID: 10720886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of tissue factor gene induction and activity using a hairpin ribozyme.
    Cavusoglu E; Chen I; Rappaport J; Marmur JD
    Circulation; 2002 May; 105(19):2282-7. PubMed ID: 12010911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery.
    Kim S; Kawamura M; Wanibuchi H; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Iwao H
    Circulation; 1995 Jul; 92(1):88-95. PubMed ID: 7788922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of transforming growth factor beta 1 during repair of arterial injury.
    Majesky MW; Lindner V; Twardzik DR; Schwartz SM; Reidy MA
    J Clin Invest; 1991 Sep; 88(3):904-10. PubMed ID: 1832175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of TGF-β by catheter-based local intravascular gene delivery does not alter the in-stent neointimal response, but enhances inflammation in pig coronary arteries.
    Chung IM; Kim J; Pak YK; Jang Y; Yang WI; Han I; Park SJ; Park SW; Huh J; Wight TN; Ueno H
    Int J Cardiol; 2010 Dec; 145(3):468-75. PubMed ID: 20053468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo antisense oligonucleotides to proliferating cell nuclear antigen and Cdc2 kinase inhibit graft coronary artery disease.
    Miniati DN; Hoyt EG; Feeley BT; Poston RS; Robbins RC
    Circulation; 2000 Nov; 102(19 Suppl 3):III237-42. PubMed ID: 11082394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta1 mRNA ameliorates renal injury in hypertensive rats.
    Tahira Y; Fukuda N; Endo M; Ueno T; Matsuda H; Saito S; Matsumoto K; Mugishima H
    J Hypertens; 2007 Mar; 25(3):671-8. PubMed ID: 17278984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of gene therapies for cardiovascular and renal diseases by nucleic acid medicines.
    Fukuda N
    Med Chem; 2006 Jan; 2(1):13-9. PubMed ID: 16787351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of a decoy against the activator protein-1 binding site suppresses neointimal thickening in rabbit balloon-injured arteries.
    Kume M; Komori K; Matsumoto T; Onohara T; Takeuchi K; Yonemitsu Y; Sugimachi K
    Circulation; 2002 Mar; 105(10):1226-32. PubMed ID: 11889018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery.
    Chang MW; Ohno T; Gordon D; Lu MM; Nabel GJ; Nabel EG; Leiden JM
    Mol Med; 1995 Jan; 1(2):172-81. PubMed ID: 8529096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.